Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
Titel:
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
Auteur:
Earl, Helena M Hiller, Louise Howard, Helen C Dunn, Janet A Young, Jennie Bowden, Sarah J McDermaid, Michelle Waterhouse, Anna K Wilson, Gregory Agrawal, Rajiv O'Reilly, Susan Bowman, Angela Ritchie, Diana M Goodman, Andrew Hickish, Tamas McAdam, Karen Cameron, David Dodwell, David Rea, Daniel W Caldas, Carlos Provenzano, Elena Abraham, Jean E Canney, Peter Crown, John P Kennedy, M John Coleman, Robert Leonard, Robert C Carmichael, James A Wardley, Andrew M Poole, Christopher J